Abstract
We investigated the effect of calcium carbonate on the oral bioavailability of gemifloxacin. Gemifloxacin was administered alone, 2 h before, simultaneously, or 2 h after calcium carbonate in 16 volunteers. Data for 320 mg of gemifloxacin alone were as follows: maximum concentration of drug in serum (C(max)),13 microg/ml; half-life, 7.33 h; and area under the concentration-time curve from 0 h to infinity (AUC( infinity )), 6.79 microg. h/ml. Only simultaneous coadministration of calcium carbonate reduced C(max) (-17%) and AUC( infinity ) (-21%) significantly.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Administration, Oral
-
Adult
-
Antacids / administration & dosage*
-
Anti-Infective Agents / administration & dosage
-
Anti-Infective Agents / adverse effects
-
Anti-Infective Agents / pharmacokinetics*
-
Calcium Carbonate / administration & dosage*
-
Cross-Over Studies
-
Drug Interactions
-
Female
-
Fluoroquinolones*
-
Gemifloxacin
-
Humans
-
Male
-
Naphthyridines / administration & dosage
-
Naphthyridines / adverse effects
-
Naphthyridines / pharmacokinetics*
Substances
-
Antacids
-
Anti-Infective Agents
-
Fluoroquinolones
-
Naphthyridines
-
Calcium Carbonate
-
Gemifloxacin